Texas 2019 - 86th Regular

Texas Senate Bill SB1646 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	86R12665 JSC-F
2	2	By: Miles S.B. No. 1646
3	3
4	4
5	5	A BILL TO BE ENTITLED
6	6	AN ACT
7	7	relating to the controlled substances listed in Penalty Groups 1,
8	8	2, and 2-A under the Texas Controlled Substances Act.
9	9	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
10	10	SECTION 1. Section 481.102, Health and Safety Code, is
11	11	amended to read as follows:
12	12	Sec. 481.102. PENALTY GROUP 1. Penalty Group 1 consists
13	13	of:
14	14	(1) the following opiates, including their isomers,
15	15	esters, ethers, salts, and salts of isomers, esters, and ethers,
16	16	unless specifically excepted, if the existence of these isomers,
17	17	esters, ethers, and salts is possible within the specific chemical
18	18	designation:
19	19	Alfentanil;
20	20	Allylprodine;
21	21	Alphacetylmethadol;
22	22	Benzethidine;
23	23	Betaprodine;
24	24	Clonitazene;
25	25	Diampromide;
26	26	Diethylthiambutene;
27	27	Difenoxin not listed in Penalty Group 3 or 4;
28	28	Dimenoxadol;
29	29	Dimethylthiambutene;
30	30	Dioxaphetyl butyrate;
31	31	Dipipanone;
32	32	Ethylmethylthiambutene;
33	33	Etonitazene;
34	34	Etoxeridine;
35	35	Furethidine;
36	36	Hydroxypethidine;
37	37	Ketobemidone;
38	38	Levophenacylmorphan;
39	39	Meprodine;
40	40	Methadol;
41	41	Moramide;
42	42	Morpheridine;
43	43	Noracymethadol;
44	44	Norlevorphanol;
45	45	Normethadone;
46	46	Norpipanone;
47	47	Phenadoxone;
48	48	Phenampromide;
49	49	Phenomorphan;
50	50	Phenoperidine;
51	51	Piritramide;
52	52	Proheptazine;
53	53	Properidine;
54	54	Propiram;
55	55	Sufentanil;
56	56	Tilidine; and
57	57	Trimeperidine;
58	58	(2) the following opium derivatives, their salts,
59	59	isomers, and salts of isomers, unless specifically excepted, if the
60	60	existence of these salts, isomers, and salts of isomers is possible
61	61	within the specific chemical designation:
62	62	Acetorphine;
63	63	Acetyldihydrocodeine;
64	64	Benzylmorphine;
65	65	Codeine methylbromide;
66	66	Codeine-N-Oxide;
67	67	Cyprenorphine;
68	68	Desomorphine;
69	69	Dihydromorphine;
70	70	Drotebanol;
71	71	Etorphine, except hydrochloride salt;
72	72	Heroin;
73	73	Hydromorphinol;
74	74	Methyldesorphine;
75	75	Methyldihydromorphine;
76	76	Monoacetylmorphine;
77	77	Morphine methylbromide;
78	78	Morphine methylsulfonate;
79	79	Morphine-N-Oxide;
80	80	Myrophine;
81	81	Nicocodeine;
82	82	Nicomorphine;
83	83	Normorphine;
84	84	Pholcodine; and
85	85	Thebacon;
86	86	(3) the following substances, however produced,
87	87	except those narcotic drugs listed in another group:
88	88	(A) Opium and opiate not listed in Penalty Group
89	89	3 or 4, and a salt, compound, derivative, or preparation of opium or
90	90	opiate, other than thebaine derived butorphanol, nalmefene and its
91	91	salts, naloxone and its salts, and naltrexone and its salts, but
92	92	including:
93	93	Codeine not listed in Penalty Group 3 or 4;
94	94	Dihydroetorphine;
95	95	Ethylmorphine not listed in Penalty Group 3
96	96	or 4;
97	97	Granulated opium;
98	98	Hydrocodone not listed in Penalty Group 3;
99	99	Hydromorphone;
100	100	Metopon;
101	101	Morphine not listed in Penalty Group 3;
102	102	Opium extracts;
103	103	Opium fluid extracts;
104	104	Oripavine;
105	105	Oxycodone;
106	106	Oxymorphone;
107	107	Powdered opium;
108	108	Raw opium;
109	109	Thebaine; and
110	110	Tincture of opium;
111	111	(B) a salt, compound, isomer, derivative, or
112	112	preparation of a substance that is chemically equivalent or
113	113	identical to a substance described by Paragraph (A), other than the
114	114	isoquinoline alkaloids of opium;
115	115	(C) Opium poppy and poppy straw;
116	116	(D) Cocaine, including:
117	117	(i) its salts, its optical, position, and
118	118	geometric isomers, and the salts of those isomers;
119	119	(ii) coca leaves and a salt, compound,
120	120	derivative, or preparation of coca leaves; and
121	121	(iii) a salt, compound, derivative, or
122	122	preparation of a salt, compound, or derivative that is chemically
123	123	equivalent or identical to a substance described by Subparagraph
124	124	(i) or (ii), other than decocainized coca leaves or extractions of
125	125	coca leaves that do not contain cocaine or ecgonine; and
126	126	(E) concentrate of poppy straw, meaning the crude
127	127	extract of poppy straw in liquid, solid, or powder form that
128	128	contains the phenanthrine alkaloids of the opium poppy;
129	129	(4) the following opiates and opioids, including their
130	130	isomers, esters, ethers, salts, and salts of isomers, if the
131	131	existence of these isomers, esters, ethers, and salts is possible
132	132	within the specific chemical designation:
133	133	(A) [Acetyl-alpha-methylfentanyl
134	134	(N-[1-(1-methyl-2- phenethyl)-4-piperidinyl]-N-phenylacetamide);
135	135	[Alpha-methylthiofentanyl (N-[1-methyl-2-(2-
136	136	thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);]
137	137	Alphaprodine;
138	138	Anileridine;
139	139	[Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-
140	140	phenethyl)-4-piperidinyl] -N-phenylpropanamide);
141	141	[Beta-hydroxy-3-methylfentanyl;]
142	142	Bezitramide;
143	143	[Carfentanil;]
144	144	Dihydrocodeine not listed in Penalty Group 3 or 4;
145	145	Diphenoxylate not listed in Penalty Group 3 or 4;
146	146	Fentanyl [or alpha-methylfentanyl, or any other
147	147	derivative of Fentanyl];
148	148	Isomethadone;
149	149	Levomethorphan;
150	150	Levorphanol;
151	151	Metazocine;
152	152	Methadone;
153	153	Methadone-Intermediate, 4-cyano-2-dimethylamino-
154	154	4, 4-diphenyl butane;
155	155	[3-methylfentanyl(N-[3-methyl-1-(2-phenylethyl)-
156	156	4-piperidyl]-N-phenylpropanamide);
157	157	[3-methylthiofentanyl(N-[3-methyl-1-(2-thienyl)
158	158	ethyl-4-piperidinyl]-N-phenylpropanamide);]
159	159	Moramide-Intermediate, 2-methyl-3-morpholino-1,
160	160	1-diphenyl-propane-carboxylic acid;
161	161	Para-fluorofentanyl(N-(4-fluorophenyl)-N-1-(2-
162	162	phenylethyl)-4-piperidinylpropanamide);
163	163	PEPAP (1-(2-phenethyl)-4-phenyl-4-
164	164	acetoxypiperidine);
165	165	Pethidine (Meperidine);
166	166	Pethidine-Intermediate-A, 4-cyano-1-methyl-4-
167	167	phenylpiperidine;
168	168	Pethidine-Intermediate-B, ethyl-4-
169	169	phenylpiperidine-4 carboxylate;
170	170	Pethidine-Intermediate-C, 1-methyl-4-
171	171	phenylpiperidine-4-carboxylic acid;
172	172	Phenazocine;
173	173	Piminodine;
174	174	Racemethorphan; and
175	175	Racemorphan[;
176	176	[Remifentanil; and
177	177	[Thiofentanyl(N-phenyl-N-[1-(2-thienyl)ethyl-4-
178	178	piperidinyl]-propanamide)]; and
179	179	(B) a substance related to fentanyl, unless
180	180	specifically excepted or controlled in another Penalty Group,
181	181	including any substance that is structurally related to fentanyl by
182	182	one or more of the following modifications:
183	183	(i) substitution on or replacement of the
184	184	phenethyl group, such as:
185	185	Alpha methyl fentanyl;
186	186	Benzyl fentanyl; and
187	187	Thionyl fentanyl (HCl);
188	188	(ii) substitution on the piperidine ring,
189	189	such as:
190	190	Carfentanil;
191	191	3-Fluorofentanyl (HCl); and
192	192	4-Phenyl fentanyl (HCl);
193	193	(iii) substitution on the aniline ring,
194	194	such as:
195	195	para-Fluorofentanyl;
196	196	meta-Fluorofentanyl; and
197	197	ortho-Fluorofentanyl; and
198	198	(iv) substitution or replacement of the
199	199	N-propionyl group, such as:
200	200	Acetyl fentanyl (HCL);
201	201	Benzodioxole fentanyl; and
202	202	Furanyl fentanyl (HCl);
203	203	(5) Flunitrazepam (trade or other name: Rohypnol);
204	204	(6) Methamphetamine, including its salts, optical
205	205	isomers, and salts of optical isomers;
206	206	(7) Phenylacetone and methylamine, if possessed
207	207	together with intent to manufacture methamphetamine;
208	208	(8) Phencyclidine, including its salts;
209	209	(9) Gamma hydroxybutyric acid (some trade or other
210	210	names: gamma hydroxybutyrate, GHB), including its salts;
211	211	(10) Ketamine;
212	212	(11) Phenazepam;
213	213	(12) U-47700;
214	214	(13) AH-7921;
215	215	(14) ADB-FUBINACA;
216	216	(15) AMB-FUBINACA; and
217	217	(16) MDMB-CHMICA.
218	218	SECTION 2. Section 481.103(a), Health and Safety Code, is
219	219	amended to read as follows:
220	220	(a) Penalty Group 2 consists of:
221	221	(1) any quantity of the following hallucinogenic
222	222	substances, their salts, isomers, and salts of isomers, unless
223	223	specifically excepted, if the existence of these salts, isomers,
224	224	and salts of isomers is possible within the specific chemical
225	225	designation:
226	226	5-(2-aminopropyl)benzofuran (5-APB);
227	227	6-(2-aminopropyl)benzofuran (6-APB);
228	228	5-(2-aminopropyl)-2,3-dihydrobenzofuran
229	229	(5-APDB);
230	230	6-(2-aminopropyl)-2,3-dihydrobenzofuran
231	231	(6-APDB);
232	232	5-(2-aminopropyl)indole (5-IT,5-API);
233	233	6-(2-aminopropyl)indole (6-IT,6-API);
234	234	1-(benzofuran-5-yl)-N-methylpropan-2-amine
235	235	(5-MAPB);
236	236	1-(benzofuran-6-yl)-N-methylpropan-2-amine
237	237	(6-MAPB);
238	238	Benzothiophenylcyclohexylpiperidine (BTCP);
239	239	8-bromo-alpha-methyl-benzo[1,2-b:4,5-b']difuran-
240	240	4-ethanamine (trade or other name: Bromo-DragonFLY);
241	241	Desoxypipradrol (2-benzhydrylpiperidine);
242	242	2, 5-dimethoxyamphetamine (some trade or other
243	243	names: 2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA);
244	244	Diphenylprolinol (diphenyl(pyrrolidin-2-yl)
245	245	methanol, D2PM);
246	246	Dronabinol (synthetic) in sesame oil and
247	247	encapsulated in a soft gelatin capsule in a U.S. Food and Drug
248	248	Administration approved drug product (some trade or other names for
249	249	Dronabinol: (a6aR-trans)-6a,7,8,10a-tetrahydro- 6,6, 9-
250	250	trimethyl-3-pentyl-6H- dibenzo [b,d]pyran-1-ol or (-)-delta-9-
251	251	(trans)- tetrahydrocannabinol);
252	252	Ethylamine Analog of Phencyclidine (some trade or
253	253	other names: N-ethyl-1-phenylcyclohexylamine, (1-
254	254	phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine,
255	255	cyclohexamine, PCE);
256	256	2-ethylamino-2-(3-methoxyphenyl)cyclohexanone
257	257	(trade or other name: methoxetamine);
258	258	Ibogaine (some trade or other names: 7-Ethyl-6,
259	259	6, beta 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H-
260	260	pyrido [1', 2':1, 2] azepino [5, 4-b] indole; tabernanthe iboga.);
261	261	5-iodo-2-aminoindane (5-IAI);
262	262	Mescaline;
263	263	5-methoxy-3, 4-methylenedioxy amphetamine;
264	264	4-methoxyamphetamine (some trade or other
265	265	names: 4-methoxy-alpha-methylphenethylamine;
266	266	paramethoxyamphetamine; PMA);
267	267	4-methoxymethamphetamine (PMMA);
268	268	2-(2-methoxyphenyl)-2-(methylamino)cyclohexanone
269	269	(some trade and other names: 2-MeO-ketamine; methoxyketamine);
270	270	1-methyl- 4-phenyl-4-propionoxypiperidine (MPPP,
271	271	PPMP);
272	272	4-methyl-2, 5-dimethoxyamphetamine (some trade
273	273	and other names: 4-methyl-2, 5-dimethoxy-alpha-
274	274	methylphenethylamine; "DOM"; "STP");
275	275	3,4-methylenedioxy methamphetamine (MDMA, MDM);
276	276	3,4-methylenedioxy amphetamine;
277	277	3,4-methylenedioxy N-ethylamphetamine (Also
278	278	known as N-ethyl MDA);
279	279	5,6-methylenedioxy-2-aminoindane (MDAI);
280	280	Nabilone (Another name for nabilone: (+)-trans-
281	281	3-(1,1-dimethylheptyl)- 6,6a, 7,8,10,10a-hexahydro-1-hydroxy- 6,
282	282	6-dimethyl-9H-dibenzo[b,d] pyran-9-one;
283	283	N-benzylpiperazine (some trade or other
284	284	names: BZP; 1-benzylpiperazine);
285	285	N-ethyl-3-piperidyl benzilate;
286	286	N-hydroxy-3,4-methylenedioxyamphetamine (Also
287	287	known as N-hydroxy MDA);
288	288	4-methylaminorex;
289	289	N-methyl-3-piperidyl benzilate;
290	290	Parahexyl (some trade or other names: 3-Hexyl-1-
291	291	hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo [b, d]
292	292	pyran; Synhexyl);
293	293	1-Phenylcyclohexylamine;
294	294	1-Piperidinocyclohexanecarbonitrile (PCC);
295	295	Pyrrolidine Analog of Phencyclidine (some trade
296	296	or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP);
297	297	Tetrahydrocannabinols, other than marihuana, and
298	298	synthetic equivalents of the substances contained in the plant, or
299	299	in the resinous extractives of Cannabis, or synthetic substances,
300	300	derivatives, and their isomers with similar chemical structure,
301	301	[and pharmacological activity] such as:
302	302	delta-9-tetrahydrocannabinolic acid (some
303	303	trade name or other name: THCA-A and THCA-B);
304	304	delta-9-tetrahydrocannabinol, and its
305	305	optical isomers;
306	306	delta-1 cis or trans tetrahydrocannabinol,
307	307	and their optical isomers;
308	308	delta-6 cis or trans tetrahydrocannabinol,
309	309	and their optical isomers;
310	310	delta-3, 4 cis or trans
311	311	tetrahydrocannabinol, and its optical isomers; or
312	312	compounds of these structures, regardless of
313	313	numerical designation of atomic positions, since nomenclature of
314	314	these substances is not internationally standardized;
315	315	Thiophene Analog of Phencyclidine (some trade or
316	316	other names: 1-[1-(2-thienyl) cyclohexyl] piperidine; 2-Thienyl
317	317	Analog of Phencyclidine; TPCP, TCP);
318	318	1-pyrrolidine (some trade or other name: TCPy);
319	319	1-(3-trifluoromethylphenyl)piperazine (trade or
320	320	other name: TFMPP); and
321	321	3,4,5-trimethoxy amphetamine;
322	322	(2) Phenylacetone (some trade or other
323	323	names: Phenyl-2-propanone; P2P, Benzymethyl ketone, methyl benzyl
324	324	ketone);
325	325	(3) unless specifically excepted or unless listed in
326	326	another Penalty Group, a material, compound, mixture, or
327	327	preparation that contains any quantity of the following substances
328	328	having a potential for abuse associated with a depressant or
329	329	stimulant effect on the central nervous system:
330	330	Aminorex (some trade or other
331	331	names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; 4,5-dihydro-5-
332	332	phenyl-2-oxazolamine);
333	333	Amphetamine, its salts, optical isomers, and
334	334	salts of optical isomers;
335	335	Cathinone (some trade or other names: 2-amino-1-
336	336	phenyl-1-propanone, alpha-aminopropiophenone, 2-
337	337	aminopropiophenone);
338	338	Etaqualone and its salts;
339	339	Etorphine Hydrochloride;
340	340	Fenethylline and its salts;
341	341	Lisdexamfetamine, including its salts, isomers,
342	342	and salts of isomers;
343	343	Mecloqualone and its salts;
344	344	Methaqualone and its salts;
345	345	Methcathinone (some trade or other names: 2-
346	346	methylamino-propiophenone; alpha-(methylamino)propriophenone;
347	347	2-(methylamino)-1-phenylpropan-1-one; alpha-N-
348	348	methylaminopropriophenone; monomethylpropion; ephedrone, N-
349	349	methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR
350	350	1431);
351	351	N-Ethylamphetamine, its salts, optical isomers,
352	352	and salts of optical isomers; and
353	353	N,N-dimethylamphetamine (some trade or other
354	354	names: N,N,alpha-trimethylbenzeneethanamine;
355	355	N,N,alpha-trimethylphenethylamine), its salts, optical isomers,
356	356	and salts of optical isomers;
357	357	(4) any compound structurally derived from
358	358	2-aminopropanal by substitution at the 1-position with any
359	359	monocyclic or fused-polycyclic ring system, including:
360	360	(A) compounds further modified by:
361	361	(i) substitution in the ring system to any
362	362	extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or
363	363	halide substituents), whether or not further substituted in the
364	364	ring system by other substituents;
365	365	(ii) substitution at the 3-position with an
366	366	alkyl substituent; or
367	367	(iii) substitution at the 2-amino nitrogen
368	368	atom with alkyl, benzyl, dialkyl, or methoxybenzyl groups, or
369	369	inclusion of the 2-amino nitrogen atom in a cyclic structure; and
370	370	(B) by example, compounds such as:
371	371	4-Methylmethcathinone (Also known as
372	372	Mephedrone);
373	373	3,4-Dimethylmethcathinone (Also known as
374	374	3,4-DMMC);
375	375	3-Fluoromethcathinone (Also known as 3-FMC);
376	376	4-Fluoromethcathinone (Also known as
377	377	Flephedrone);
378	378	3,4-Methylenedioxy-N-methylcathinone (Also
379	379	known as Methylone);
380	380	3,4-Methylenedioxypyrovalerone (Also known
381	381	as MDPV);
382	382	alpha-Pyrrolidinopentiophenone (Also known
383	383	as alpha-PVP);
384	384	Naphthylpyrovalerone (Also known as
385	385	Naphyrone);
386	386	alpha-Methylamino-valerophenone (Also known
387	387	as Pentedrone);
388	388	beta-Keto-N-methylbenzodioxolylpropylamine
389	389	(Also known as Butylone);
390	390	beta-Keto-N-methylbenzodioxolylpentanamine
391	391	(Also known as Pentylone);
392	392	beta-Keto-Ethylbenzodioxolylbutanamine
393	393	(Also known as Eutylone); and
394	394	3,4-methylenedioxy-N-ethylcathinone (Also
395	395	known as Ethylone);
396	396	(5) any compound structurally derived from tryptamine
397	397	(3-(2-aminoethyl)indole) or a ring-hydroxy tryptamine:
398	398	(A) by modification in any of the following ways:
399	399	(i) by substitution at the amine nitrogen
400	400	atom of the sidechain to any extent with alkyl or alkenyl groups or
401	401	by inclusion of the amine nitrogen atom of the side chain (and no
402	402	other atoms of the side chain) in a cyclic structure;
403	403	(ii) by substitution at the carbon atom
404	404	adjacent to the nitrogen atom of the side chain (alpha-position)
405	405	with an alkyl or alkenyl group;
406	406	(iii) by substitution in the 6-membered
407	407	ring to any extent with alkyl, alkoxy, haloalkyl, thioaklyl,
408	408	alkylenedioxy, or halide substituents; or
409	409	(iv) by substitution at the 2-position of
410	410	the tryptamine ring system with an alkyl substituent; and
411	411	(B) including:
412	412	(i) ethers and esters of the controlled
413	413	substances listed in this subdivision; and
414	414	(ii) by example, compounds such as:
415	415	alpha-ethyltryptamine;
416	416	alpha-methyltryptamine;
417	417	Bufotenine (some trade and other names:
418	418	3-(beta-Dimethylaminoethyl)-5-hydroxyindole;
419	419	3-(2-dimethylaminoethyl)- 5- indolol; N, N-dimethylserotonin;
420	420	5-hydroxy-N, N- dimethyltryptamine; mappine);
421	421	Diethyltryptamine (some trade and
422	422	other names: N, N-Diethyltryptamine, DET);
423	423	Dimethyltryptamine (trade or other
424	424	name: DMT);
425	425	5-methoxy-N, N-diisopropyltryptamine
426	426	(5-MeO-DiPT);
427	427	O-Acetylpsilocin (Trade or other name:
428	428	4-Aco-DMT);
429	429	Psilocin; and
430	430	Psilocybin;
431	431	(6) 2,5-Dimethoxyphenethylamine and any compound
432	432	structurally derived from 2,5-Dimethoxyphenethylamine by
433	433	substitution at the 4-position of the phenyl ring to any extent
434	434	(including alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide
435	435	substituents), including, by example, compounds such as:
436	436	4-Bromo-2,5-dimethoxyphenethylamine (trade or
437	437	other name: 2C-B);
438	438	4-Chloro-2,5-dimethoxyphenethylamine (trade or
439	439	other name: 2C-C);
440	440	2,5-Dimethoxy-4-methylphenethylamine (trade or
441	441	other name: 2C-D);
442	442	4-Ethyl-2,5-dimethoxyphenethylamine (trade or
443	443	other name: 2C-E);
444	444	4-Iodo-2,5-dimethoxyphenethylamine (trade or
445	445	other name: 2C-I);
446	446	2,5-Dimethoxy-4-nitrophenethylamine (trade or
447	447	other name: 2C-N);
448	448	2,5-Dimethoxy-4-(n)-propylphenethylamine (trade
449	449	or other name: 2C-P);
450	450	4-Ethylthio-2,5-dimethoxyphenethylamine (trade
451	451	or other name: 2C-T-2);
452	452	4-Isopropylthio-2,5-dimethoxyphenethylamine
453	453	(trade or other name: 2C-T-4); and
454	454	2,5-Dimethoxy-4-(n)-propylthiophenethylamine
455	455	(trade or other name: 2C-T-7); and
456	456	(7) 2,5-Dimethoxyamphetamine and any compound
457	457	structurally derived from 2,5-Dimethoxyamphetamine by substitution
458	458	at the 4-position of the phenyl ring to any extent (including alkyl,
459	459	alkoxy, alkylenedioxy, haloalkyl, or halide substituents),
460	460	including, by example, compounds such as:
461	461	4-Ethylthio-2,5-dimethoxyamphetamine (trade or
462	462	other name: Aleph-2);
463	463	4-Isopropylthio-2,5-dimethoxyamphetamine (trade
464	464	or other name: Aleph-4);
465	465	4-Bromo-2,5-dimethoxyamphetamine (trade or other
466	466	name: DOB);
467	467	4-Chloro-2,5-dimethoxyamphetamine (trade or
468	468	other name: DOC);
469	469	2,5-Dimethoxy-4-ethylamphetamine (trade or other
470	470	name: DOET);
471	471	4-Iodo-2,5-dimethoxyamphetamine (trade or other
472	472	name: DOI);
473	473	2,5-Dimethoxy-4-methylamphetamine (trade or
474	474	other name: DOM);
475	475	2,5-Dimethoxy-4-nitroamphetamine (trade or other
476	476	name: DON);
477	477	4-Isopropyl-2,5-dimethoxyamphetamine (trade or
478	478	other name: DOIP); and
479	479	2,5-Dimethoxy-4-(n)-propylamphetamine (trade or
480	480	other name: DOPR).
481	481	SECTION 3. Section 481.1031, Health and Safety Code, is
482	482	amended to read as follows:
483	483	Sec. 481.1031. PENALTY GROUP 2-A. (a) In this section:
484	484	(1) "Core component" is one of the following:
485	485	azaindole, beta carboline, benzimidazole, benzothiazole,
486	486	carbazole, gamma carboline, imidazole, indane, indazole, indene,
487	487	indole, naphthalene, pyrazole, pyrazolopyridine, pyridine, or
488	488	pyrrole.
489	489	(2) "Group A component" is one of the following:
490	490	adamantane, benzylpiperazine, benzyl, cumene [benzene],
491	491	cycloalkylmethyl, cyclopropylmethyl, isoquinoline,
492	492	methylpiperazine, naphthalene, pyrrolidine, phenyl, quinoline,
493	493	tetrahydronaphthalene, tetramethylcyclopropane, amino oxobutane,
494	494	amino methyl ovobutane, amino dimethyl oxobutane, amino phenyl
495	495	oxopropane, amino oxopentane, ethoxy oxobutane, ethoxy methyl
496	496	oxobutane, ethoxy dimethyl oxobutane, ethoxy phenyl oxopropane,
497	497	ethoxy oxopentane, methoxy oxobutane, methoxy methyl oxobutane
498	498	[methyl methoxy oxobutane], methoxy dimethyl oxobutane, methoxy
499	499	phenyl oxopropane, methoxy oxopentane, or any substituted [an]
500	500	amino acid.
501	501	(3) "Link component" is one of the following
502	502	functional groups: carboxamide, carboxylate, hydrazide,
503	503	methanone (ketone), ethanone, methanediyl (methylene bridge), or
504	504	methine.
505	505	(b) Penalty Group 2-A consists of any material, compound,
506	506	mixture, or preparation that contains any quantity of a natural or
507	507	synthetic chemical substance, including its salts, isomers, and
508	508	salts of isomers, listed by name in this subsection or contained
509	509	within one of the structural classes defined in this subsection:
510	510	(1) WIN-55,212-2;
511	511	(2) Cyclohexylphenol: any compound structurally
512	512	derived from 2-(3-hydroxycyclohexyl)phenol by substitution at the
513	513	5-position of the phenolic ring, (N-methylpiperidin-2-yl)alkyl,
514	514	(4-tetrahydropyran)alkyl, or 2-(4-morpholinyl)alkyl, whether or
515	515	not substituted in the cyclohexyl ring to any extent, including:
516	516	JWH-337;
517	517	JWH-344;
518	518	CP-55,940;
519	519	CP-47,497; and
520	520	analogues of CP-47,497;
521	521	(3) Cannabinol derivatives, except where contained in
522	522	marihuana, including tetrahydro derivatives of cannabinol and
523	523	3-alkyl homologues of cannabinol or of its tetrahydro derivatives,
524	524	such as:
525	525	Nabilone;
526	526	HU-210; and
527	527	HU-211;
528	528	(4) Tetramethylcyclopropyl thiazole: any compound
529	529	structurally derived from 2,2,3,3-tetramethyl-N-(thiazol-
530	530	2-ylidene)cyclopropanecarboxamide by substitution at the nitrogen
531	531	atom of the thiazole ring, whether or not further substituted in the
532	532	thiazole ring to any extent, whether or not substituted in the
533	533	tetramethylcyclopropyl ring to any extent, such as [including]:
534	534	A-836,339;
535	535	(5) any compound containing a core component
536	536	substituted at the 1-position to any extent, and substituted at the
537	537	3-position with a link component attached to a group A component,
538	538	whether or not the core component or group A component are further
539	539	substituted to any extent, such as [including]:
540	540	Naphthoylindane;
541	541	Naphthoylindazole (THJ-018);
542	542	Naphthyl methyl indene (JWH-171);
543	543	Naphthoylindole (JWH-018);
544	544	Quinolinoyl pyrazole carboxylate (Quinolinyl
545	545	fluoropentyl fluorophenyl pyrazole carboxylate);
546	546	Naphthoyl pyrazolopyridine; and
547	547	Naphthoylpyrrole (JWH-030);
548	548	(6) any compound containing a core component
549	549	substituted at the 1-position to any extent, and substituted at the
550	550	2-position with a link component attached to a group A component,
551	551	whether or not the core component or group A component are further
552	552	substituted to any extent, such as [including]:
553	553	Naphthoylbenzimidazole (JWH-018 Benzimidazole);
554	554	and
555	555	Naphthoylimidazole;
556	556	(7) any compound containing a core component
557	557	substituted at the 3-position to any extent, and substituted at the
558	558	2-position with a link component attached to a group A component,
559	559	whether or not the core component or group A component are further
560	560	substituted to any extent, such as [including]:
561	561	Naphthoyl benzothiazole; [and]
562	562	(8) any compound containing a core component
563	563	substituted at the 9-position to any extent, and substituted at the
564	564	3-position with a link component attached to a group A component,
565	565	whether or not the core component or group A component are further
566	566	substituted to any extent, including:
567	567	Naphthoylcarbazole (EG-018); and
568	568	Synthetic chemical compounds with a carbazole
569	569	core structure, regardless of numerical designation of atomic
570	570	positions, since this core structure is symmetrical;
571	571	(9) any compound containing a core component
572	572	substituted at the 1-position to any extent and substituted at the
573	573	5-position with a link component attached to a group A component,
574	574	regardless of whether the core component or group A component are
575	575	further substituted to any extent, such as:
576	576	5-fluoro-3,5-ADB-PFUPPYCA (5f-AB-PFUPPYCA);
577	577	(10) any compound containing a core component
578	578	substituted at the 2-position to any extent and substituted at the
579	579	3-position with a link component attached to a group A component,
580	580	regardless of whether the core component or group A component are
581	581	further substituted to any extent, such as:
582	582	AB-CHMINACA (2H) indazole; and
583	583	(11) any compound containing a core component
584	584	substituted at the 5-position to any extent and substituted at the
585	585	2-position with a group A component, regardless of whether the core
586	586	component or group A component are further substituted to any
587	587	extent, such as:
588	588	Cumyl-PeGACLONE.
589	589	(c) In this section, a synthetic chemical substance
590	590	analogue is:
591	591	(1) any substance, unless specifically excepted, that
592	592	has two of the three components as defined by Subsection (a) and a
593	593	numerical core-link position that is listed in Subsection (b)(5),
594	594	(6), (7), (8), (9), or (10);
595	595	(2) any substance, unless specifically excepted, that
596	596	has a core, link, and group A component as defined by Subsection (a)
597	597	but does not have a numerical core-link position that is listed in
598	598	Subsection (b)(5), (6), (7), (8), (9), or (10); or
599	599	(3) any substance, unless specifically excepted, that
600	600	has a core component or group A component as defined by Subsection
601	601	(a) and a numerical core-group A position that is listed in
602	602	Subsection (b)(11).
603	603	SECTION 4. The change in law made by this Act applies only
604	604	to an offense committed on or after the effective date of this Act.
605	605	An offense committed before the effective date of this Act is
606	606	governed by the law in effect on the date the offense was committed,
607	607	and the former law is continued in effect for that purpose. For
608	608	purposes of this section, an offense was committed before the
609	609	effective date of this Act if any element of the offense occurred
610	610	before that date.
611	611	SECTION 5. This Act takes effect September 1, 2019.